The 20 Best Type 2 Diabetes (T2D) Doctors Near Me in Brighton, MI

Kara Mizokami-Stout, MD, MSc is an Assistant Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology, and Diabetes. She attended medical school and internal medicine residency at the University of Colorado. She then completed her endocrinology fellowship at the University of Michigan. She joined the faculty at the University of Michigan in 2017 and has a dual appointment at the Ann Arbor VA.Dr. Mizokami-Stout’s practice focuses on type 1 diabetes, type 2 diabetes, and general endocrinology. She also conducts health services research in the field of diabetes. Dr. Mizokami is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Diabetic Neuropathy, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Graves Disease. Dr. Mizokami is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

William H. Herman is the Stefan S. Fajans/GlaxoSmithKline Professor of Diabetes, Professor of Internal Medicine in the Division of Metabolism, Endocrinology, and Diabetes and Professor of Epidemiology in the School of Public Health. He completed his undergraduate degree at Yale University and received his medical degree from Boston University. He gained a Masters of Public Health (Epidemiology) from the University of Michigan. Professor Herman's interests include clinical diabetes and diabetes epidemiology, especially in the areas of surveillance, screening, treatment, cost-effective analysis, and health policy. He has authored more than 400 original research papers, reviews and textbook chapters and is U-M Principal Investigator for the Diabetes Control and Complications Trial (DCCT), Epidemiology of Diabetes Interventions and Complications (EDIC), Diabetes Prevention Program (DPP), Diabetes Prevention Program Outcomes Study (DPPOS), and The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Professor Herman received the American Diabetes Association's Kelly West Award for outstanding achievement in diabetes epidemiology in 2006 and the U-M Dean's Award for Clinical and Health Services Research in 2007. From 2018 to 2021, he chaired the National Clinical Care Commission, a federal advisory committee charged with advising the Congress how to leverage federal policies and programs to better prevent and control diabetes in the United States. He has been recognized by Best Doctors as a Best Doctor in America for more than 10 years. Dr. Herman is rated as an Elite provider by MediFind in the treatment of Type 2 Diabetes (T2D). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), Diabetic Neuropathy, and Gastric Bypass. Dr. Herman is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

David T. Broome, MD, is a Clinical Assistant Professor of Medicine in the Metabolism, Endocrinology, and Diabetes (MEND) Division of the University of Michigan. Dr. Broome's clinical and research interests are in Type 1 Diabetes Mellitus, Atypical Diabetes and Monogenic Diabetes (including MODY), Type 2 Diabetes Mellitus, Hypoglycemia, Thyroid Cancer and Primary Hyperparathyroidism. Dr. Broome is dedicated to progress in scholarly work, translational research, and was the recipient of the Tait Endowed Research Scholarship for his work in diabetes in medical school, selected to the Clinical Scholars Program in residency, and several research and teaching thereafter, including: the Cleveland Clinic Foundation Endocrinology & Metabolism Institute Research Award, ENDO Experience Travel Award, the Cleveland Clinic Lerner College of Medicine Excellence in Teaching Award, the AACE Domestic Resident Travel Grant, and most recently the Michigan Clinical Trials Academy. Dr. Broome currently serves as a Review Editor on the editorial board for Frontiers in Clinical Diabetes and Healthcare. In his free time, Dr. Broome enjoys ice hockey, cycling, and spending time with family and friends on the beach in Holland, MI. Dr. Broome is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Familial Partial Lipodystrophy, Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Gestational Diabetes, and Parathyroidectomy. Dr. Broome is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Nada Fanous is an Internal Medicine specialist and an Endocrinologist practicing medicine in Brighton, Michigan. Dr. Fanous is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Hashimoto Thyroiditis, and Hyperparathyroidism.

Dr. Peirce graduated from Hope College and then attended the University of Michigan Medical School. She completed her residency in Internal Medicine at the University of Wisconsin in Madison and then served as the Primary Care Chief Resident. She is interested in preventive health care, women’s health, and medical student and resident education. She enjoys hiking, kayaking, and spending time with family, friends, and her dog. Dr. Peirce is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Sciatica, Obesity, and Obesity in Children.

Mark Ealovega is a primary care provider, practicing in Internal Medicine in Brighton, Michigan. Dr. Ealovega is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Bicuspid Aortic Valve, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Familial Hypertension. Dr. Ealovega is board certified in Internal Medicine.

Dr Scowden grew up just outside of Flint MI and was very pleased to return “home” after completing training. In addition to her primary role of patient care, she also works with our resident physicians longitudinally during their internal medicine training as well as hosts medical students for their internal medicine rotations. She has three children and loves her dogs as if they were human children as well! When not working or parenting, she is likely to be reading, working outside on some project or another, or spending time with family. Dr. Scowden is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Type 2 Diabetes (T2D).

Annissa Hammoud is a primary care provider, practicing in Internal Medicine and Pediatrics in Brighton, Michigan. Dr. Hammoud is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Vertigo, and Cleft Tongue. Dr. Hammoud is board certified in Internal Medicine and Pediatrics.

Dr. Elif Oral is a professor in the Division of Metabolism, Endocrinology and Diabetes (MEND) at the University of Michigan. She completed her medical education in her home country of Turkey at the University of Istanbul. In 1996, she completed her residency in Internal Medicine at Sinai Hospital Detroit (Michigan). She then completed a fellowship in Endocrinology, Metabolism and Diabetes at the National Institute of Health, where she also chose to stay as a Senior Fellow under the mentorship of Drs SimeonTaylor and Phillip Gorden in in the Diabetes Branch of NIDDK.Since joining the University of Michigan in 2002 as an Assistant Professor of Medicine, along with her regular faculty responsibilities, Dr. Oral also completed a Masters of Science Degree in Clinical Research Design and Biostatistics at the School of Public Health. Her clinical interests are in insulin resistance, obesity, lipid disorders, and diabetes.Dr Oral's research focuses on the importance of adipocytes in human metabolism and adipocyte hormones such as leptin. She is best known for her work showing the remarkable efficacy of leptin in rare lipodystrophy syndromes. Metreleptin received approval by the FDA (2014) and EMA (2016) as a treatment for lipodystrophy owing to a large part to her original vision and work. These studies provided the basis for her current work with three big goals: identification of novel metabolic diseases, discovery of new disease mechanisms and finding treatments for patients afflicted with these disorders. In addition to her roles as physician, educator, and researcher, Dr Oral is also the director of two programs at MEND: Atypical Diabetes Program and Obesity and Metabolic Disorders Program. She directed the Post-Bariatric Surgery Care Program from 2012 to 2021 and continues to conduct research on the cohort of patients who had bariatric surgery performed in the Michigan Bariatric Surgery program. Dr. Oral is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Familial Partial Lipodystrophy, Congenital Generalized Lipodystrophy, Familial Hypertriglyceridemia, Gastric Bypass, and Sleeve Gastrectomy. Dr. Oral is board certified in Endocrinology, Diabetes & Metabolism.

Dr. Lynn Ang is currently a Clinical Associate Professor in the Metabolism, Endocrinology, and Diabetes Division, Internal Medicine Department at University of Michigan. Dr. Ang is one of the principle attending physicians for the Diabetes Transition Program. Dr. Ang’s clinical and research interests are in the fields of implementing optimal management of inpatient and outpatient hyperglycemia, creating protocols for inpatient hospital guidelines, identifying biomarkers to predict the development or progression of diabetic complications, detecting the earliest stages of complications to prevent progression of diseases, and developing sensitive diagnostic methods/treatment for those complications. Dr. Ang also serves as a Co-Director of Hospital Intensive Insulin Program. Dr. Ang has been actively involving in teaching internal medicine and podiatry residents, endocrinology fellows, and medical students in both ambulatory and inpatient clinical settings. She was a recipient of Goran Sundkvist Young Investigators Award for Clinical Science 2022. Dr. Ang is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Diabetic Neuropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young. Dr. Ang is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Jennifer Franzese is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Franzese is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Maturity Onset Diabetes of the Young, and Thyroid Nodule.

Liselle Douyon is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Douyon is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Thyroid Nodule, and Juvenile Primary Osteoporosis.

Cristina Nieves is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Nieves is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Toxic Nodular Goiter, Thyroid Storm, Type 2 Diabetes (T2D), and Low Blood Sugar. Dr. Nieves is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Nazanene H. Esfandiari, MD, is a Clinical Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes (MEND). Dr. Esfandiari received her medical degree from the University of Bordeaux in France, completed internal medicine residency in France and at UMASS Memorial Health Center in Massachusetts, and then completed fellowship in endocrinology at the University of Michigan. She joined the faculty at the University of Michigan in 2003. She was inducted into Clinical Excellence Society at the University of Michigan in 2014. She is the MEND Service Chief, Co-director of Hospital Intensive Insulin Program (HIIP) and Assistant Chief for the Inpatient Endocrine Consult.Dr. Esfandiari’s practice focuses on thyroid cancer, thyroid disorders, post bariatric care, and diabetes. She is also interested in medical education and is the Co-director of the Endocrine Sequence at the University of Michigan Medical School. In addition, Dr. Esfandiari has served in several national committees at the Endocrine Society and American Thyroid Association (ATA). Dr. Esfandiari is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Anaplastic Thyroid Cancer, Gastric Bypass, and Thyroidectomy. Dr. Esfandiari is board certified in Endocrinology, Diabetes & Metabolism.

Lisa Oltmanns, MD joined the Division of General Medicine on November 1, 2021.? She is working as a primary care physician at the Brighton Health Center.? She is board-certified in Internal Medicine. She was born and raised in Michigan and earned her undergraduate and medical degrees from the University of Michigan. She completed her internal medicine residency training at the University of Wisconsin. She has over 20 years of experience and specializes in primary care, disease prevention, and health maintenance. She is truly concerned about the well-being of her patients and enjoys building long-lasting relationships with them. Her care philosophy is to provide personalized, evidence-based care. In her free time, she loves to travel and explore nature. Dr. Oltmanns is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses High Cholesterol, Obesity in Children, Familial Hypertension, and Hypertension.

Amanda Cox is a primary care provider, practicing in Internal Medicine in Brighton, Michigan. Dr. Cox is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Primary Biliary Cholangitis, Reynolds Syndrome, Maturity Onset Diabetes of the Young, and Vertigo. Dr. Cox is board certified in Internal Medicine.

Nazar Mohammad is an Internal Medicine specialist and an Endocrinologist practicing medicine in Brighton, Michigan. Dr. Mohammad is rated as an Experienced provider by MediFind in the treatment of Type 2 Diabetes (T2D). His clinical expertise encompasses Hyperparathyroidism, Familial Glucocorticoid Deficiency, Glucocorticoid Resistance, and Hypoaldosteronism.

David Mika is a primary care provider, practicing in Family Medicine in Brighton, Michigan. Dr. Mika is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Fragile X Syndrome, and Fragile XE Syndrome.

Ben Lee is a primary care provider, practicing in Internal Medicine in Brighton, Michigan. Dr. Lee is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Glossitis, Pernicious Anemia, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Mark Zawisa is a primary care provider, practicing in Family Medicine in Brighton, Michigan. Dr. Zawisa is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Hypertension, Glucocorticoid-Remediable Aldosteronism, and Familial Hypertension.